Anand BS - Search Results

1

Drug treatment of the complications of cirrhosis in the older adult.

Anand BS. Anand BS. Drugs Aging. 2001;18(8):575-85. doi: 10.2165/00002512-200118080-00002. Drugs Aging. 2001. PMID: 11587244 Review.

2

Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database.

Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Singal AK, et al. Among authors: anand bs. Hepatology. 2012 May;55(5):1398-405. doi: 10.1002/hep.25544. Epub 2012 Mar 18. Hepatology. 2012. PMID: 22213344

3

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma.

Singal AK, Freeman DH Jr, Anand BS. Singal AK, et al. Among authors: anand bs. Aliment Pharmacol Ther. 2010 Oct;32(7):851-8. doi: 10.1111/j.1365-2036.2010.04414.x. Aliment Pharmacol Ther. 2010. PMID: 20659285 Review.

4

Young v adult cirrhotics: a prospective, comparative analysis of the clinical profile, natural course and survival.

Sarin SK, Chari S, Sundaram KR, Ahuja RK, Anand BS, Broor SL. Sarin SK, et al. Among authors: anand bs. Gut. 1988 Jan;29(1):101-7. doi: 10.1136/gut.29.1.101. Gut. 1988. PMID: 3343002 Free PMC article.

5

Outcomes after liver transplantation for combined alcohol and hepatitis C virus infection.

Khan R, Singal AK, Anand BS. Khan R, et al. Among authors: anand bs. World J Gastroenterol. 2014 Sep 14;20(34):11935-8. doi: 10.3748/wjg.v20.i34.11935. World J Gastroenterol. 2014. PMID: 25232228 Free PMC article. Review.

6

Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality.

Singal AK, Kuo YF, Anand BS. Singal AK, et al. Among authors: anand bs. Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1178-84. doi: 10.1097/MEG.0b013e328355cce0. Eur J Gastroenterol Hepatol. 2012. PMID: 22735607

7

Definition, epidemiology and magnitude of alcoholic hepatitis.

Basra S, Anand BS. Basra S, et al. Among authors: anand bs. World J Hepatol. 2011 May 27;3(5):108-13. doi: 10.4254/wjh.v3.i5.108. World J Hepatol. 2011. PMID: 21731902 Free PMC article.

8

Comment on a systematic review of randomized trials of peginterferon alpha-2a versus peginterferon alpha-2b in chronic hepatitis C.

Singal AK, Jampana SC, Anand BS. Singal AK, et al. Among authors: anand bs. Hepatology. 2011 Jun;53(6):2151. doi: 10.1002/hep.24165. Epub 2011 Apr 29. Hepatology. 2011. PMID: 21538429 No abstract available.

9

Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naïve patients with hepatitis C virus infection: meta-analysis of randomized controlled trials.

Singal AK, Jampana SC, Anand BS. Singal AK, et al. Among authors: anand bs. Dig Dis Sci. 2011 Aug;56(8):2221-6. doi: 10.1007/s10620-011-1765-0. Epub 2011 Jun 4. Dig Dis Sci. 2011. PMID: 21643737 Review.

10

Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.

Cozen ML, Ryan JC, Shen H, Cheung R, Kaplan DE, Pocha C, Brau N, Aytaman A, Schmidt WN, Pedrosa M, Anand BS, Chang KM, Morgan T, Monto A. Cozen ML, et al. Among authors: anand bs. Dig Dis Sci. 2016 Jun;61(6):1744-56. doi: 10.1007/s10620-016-4122-5. Epub 2016 Apr 8. Dig Dis Sci. 2016. PMID: 27059981 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results